190 related articles for article (PubMed ID: 24156260)
1. Pan-amyloid oligomer specific scFv antibody attenuates memory deficits and brain amyloid burden in mice with Alzheimer's disease.
Zhao M; Wang SW; Wang YJ; Zhang R; Li YN; Su YJ; Zhou WW; Yu XL; Liu RT
Curr Alzheimer Res; 2014 Jan; 11(1):69-78. PubMed ID: 24156260
[TBL] [Abstract][Full Text] [Related]
2. Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses.
Zhang X; Sun XX; Xue D; Liu DG; Hu XY; Zhao M; Yang SG; Yang Y; Xia YJ; Wang Y; Liu RT
Biochim Biophys Acta; 2011 Dec; 1814(12):1703-12. PubMed ID: 21979582
[TBL] [Abstract][Full Text] [Related]
3. A Novel scFv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes.
Hu M; Zhang J; Yang J; Cao Y; Qi J
J Mol Neurosci; 2018 Sep; 66(1):1-9. PubMed ID: 30062438
[TBL] [Abstract][Full Text] [Related]
4. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
6. Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific scFv antibody and class A scavenger receptor activator show therapeutic potentials for Alzheimer's Disease.
Liu XG; Zhang L; Lu S; Liu DQ; Huang YR; Zhu J; Zhou WW; Yu XL; Liu RT
J Nanobiotechnology; 2020 Nov; 18(1):160. PubMed ID: 33160377
[TBL] [Abstract][Full Text] [Related]
7. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
8. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Cattepoel S; Hanenberg M; Kulic L; Nitsch RM
PLoS One; 2011 Apr; 6(4):e18296. PubMed ID: 21483675
[TBL] [Abstract][Full Text] [Related]
9. Bispecific Antibody Fragment Targeting APP and Inducing α-Site Cleavage Restores Neuronal Health in an Alzheimer's Mouse Model.
He P; Xin W; Schulz P; Sierks MR
Mol Neurobiol; 2019 Nov; 56(11):7420-7432. PubMed ID: 31041656
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional Superparamagnetic Iron Oxide Nanoparticles Conjugated with Aβ Oligomer-Specific scFv Antibody and Class A Scavenger Receptor Activator Show Early Diagnostic Potentials for Alzheimer's Disease.
Liu XG; Zhang L; Lu S; Liu DQ; Zhang LX; Yu XL; Liu RT
Int J Nanomedicine; 2020; 15():4919-4932. PubMed ID: 32764925
[TBL] [Abstract][Full Text] [Related]
11. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
13. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
[TBL] [Abstract][Full Text] [Related]
14. Effects of an amyloid-beta 1-42 oligomers antibody screened from a phage display library in APP/PS1 transgenic mice.
Wang J; Li N; Ma J; Gu Z; Yu L; Fu X; Liu X; Wang J
Brain Res; 2016 Mar; 1635():169-79. PubMed ID: 26820640
[TBL] [Abstract][Full Text] [Related]
15. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
16. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
17. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
[TBL] [Abstract][Full Text] [Related]
18. Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice.
Rasool S; Martinez-Coria H; Wu JW; LaFerla F; Glabe CG
J Neurochem; 2013 Aug; 126(4):473-82. PubMed ID: 23672786
[TBL] [Abstract][Full Text] [Related]
19. Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer.
Perche F; Uchida S; Akiba H; Lin CY; Ikegami M; Dirisala A; Nakashima T; Itaka K; Tsumoto K; Kataoka K
Curr Alzheimer Res; 2017; 14(3):295-302. PubMed ID: 27829339
[TBL] [Abstract][Full Text] [Related]
20. Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease.
Giménez-Llort L; Rivera-Hernández G; Marin-Argany M; Sánchez-Quesada JL; Villegas S
MAbs; 2013; 5(5):665-77. PubMed ID: 23884018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
